Cargando…
T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease
In the current study, we have evaluated the performance of magnetic resonance (MR) T1rho (T(1ρ)) imaging and CSF biomarkers (T-tau, P-tau and Aβ-42) in characterization of Alzheimer's disease (AD) patients from mild cognitive impairment (MCI) and control subjects. With informed consent, AD (n =...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375645/ https://www.ncbi.nlm.nih.gov/pubmed/25844314 http://dx.doi.org/10.1016/j.nicl.2015.02.016 |
_version_ | 1782363608537104384 |
---|---|
author | Haris, Mohammad Yadav, Santosh K. Rizwan, Arshi Singh, Anup Cai, Kejia Kaura, Deepak Wang, Ena Davatzikos, Christos Trojanowski, John Q. Melhem, Elias R. Marincola, Francesco M. Borthakur, Arijitt |
author_facet | Haris, Mohammad Yadav, Santosh K. Rizwan, Arshi Singh, Anup Cai, Kejia Kaura, Deepak Wang, Ena Davatzikos, Christos Trojanowski, John Q. Melhem, Elias R. Marincola, Francesco M. Borthakur, Arijitt |
author_sort | Haris, Mohammad |
collection | PubMed |
description | In the current study, we have evaluated the performance of magnetic resonance (MR) T1rho (T(1ρ)) imaging and CSF biomarkers (T-tau, P-tau and Aβ-42) in characterization of Alzheimer's disease (AD) patients from mild cognitive impairment (MCI) and control subjects. With informed consent, AD (n = 27), MCI (n = 17) and control (n = 17) subjects underwent a standardized clinical assessment and brain MRI on a 1.5-T clinical-scanner. T(1ρ) images were obtained at four different spin-lock pulse duration (10, 20, 30 and 40 ms). T(1ρ) maps were generated by pixel-wise fitting of signal intensity as a function of the spin-lock pulse duration. T(1ρ) values from gray matter (GM) and white matter (WM) of medial temporal lobe were calculated. The binary logistic regression using T(1ρ) and CSF biomarkers as variables was performed to classify each group. T(1ρ) was able to predict 77.3% controls and 40.0% MCI while CSF biomarkers predicted 81.8% controls and 46.7% MCI. T(1ρ) and CSF biomarkers in combination predicted 86.4% controls and 66.7% MCI. When comparing controls with AD, T(1ρ) predicted 68.2% controls and 73.9% AD, while CSF biomarkers predicted 77.3% controls and 78.3% for AD. Combination of T(1ρ) and CSF biomarkers improved the prediction rate to 81.8% for controls and 82.6% for AD. Similarly, on comparing MCI with AD, T(1ρ) predicted 35.3% MCI and 81.9% AD, whereas CSF biomarkers predicted 53.3% MCI and 83.0% AD. Collectively CSF biomarkers and T(1ρ) were able to predict 59.3% MCI and 84.6% AD. On receiver operating characteristic analysis T(1ρ) showed higher sensitivity while CSF biomarkers showed greater specificity in delineating MCI and AD from controls. No significant correlation between T(1ρ) and CSF biomarkers, between T(1ρ) and age, and between CSF biomarkers and age was observed. The combined use of T(1ρ) and CSF biomarkers have promise to improve the early and specific diagnosis of AD. Furthermore, disease progression form MCI to AD might be easily tracked using these two parameters in combination. |
format | Online Article Text |
id | pubmed-4375645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-43756452015-04-03 T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease Haris, Mohammad Yadav, Santosh K. Rizwan, Arshi Singh, Anup Cai, Kejia Kaura, Deepak Wang, Ena Davatzikos, Christos Trojanowski, John Q. Melhem, Elias R. Marincola, Francesco M. Borthakur, Arijitt Neuroimage Clin Regular Article In the current study, we have evaluated the performance of magnetic resonance (MR) T1rho (T(1ρ)) imaging and CSF biomarkers (T-tau, P-tau and Aβ-42) in characterization of Alzheimer's disease (AD) patients from mild cognitive impairment (MCI) and control subjects. With informed consent, AD (n = 27), MCI (n = 17) and control (n = 17) subjects underwent a standardized clinical assessment and brain MRI on a 1.5-T clinical-scanner. T(1ρ) images were obtained at four different spin-lock pulse duration (10, 20, 30 and 40 ms). T(1ρ) maps were generated by pixel-wise fitting of signal intensity as a function of the spin-lock pulse duration. T(1ρ) values from gray matter (GM) and white matter (WM) of medial temporal lobe were calculated. The binary logistic regression using T(1ρ) and CSF biomarkers as variables was performed to classify each group. T(1ρ) was able to predict 77.3% controls and 40.0% MCI while CSF biomarkers predicted 81.8% controls and 46.7% MCI. T(1ρ) and CSF biomarkers in combination predicted 86.4% controls and 66.7% MCI. When comparing controls with AD, T(1ρ) predicted 68.2% controls and 73.9% AD, while CSF biomarkers predicted 77.3% controls and 78.3% for AD. Combination of T(1ρ) and CSF biomarkers improved the prediction rate to 81.8% for controls and 82.6% for AD. Similarly, on comparing MCI with AD, T(1ρ) predicted 35.3% MCI and 81.9% AD, whereas CSF biomarkers predicted 53.3% MCI and 83.0% AD. Collectively CSF biomarkers and T(1ρ) were able to predict 59.3% MCI and 84.6% AD. On receiver operating characteristic analysis T(1ρ) showed higher sensitivity while CSF biomarkers showed greater specificity in delineating MCI and AD from controls. No significant correlation between T(1ρ) and CSF biomarkers, between T(1ρ) and age, and between CSF biomarkers and age was observed. The combined use of T(1ρ) and CSF biomarkers have promise to improve the early and specific diagnosis of AD. Furthermore, disease progression form MCI to AD might be easily tracked using these two parameters in combination. Elsevier 2015-02-26 /pmc/articles/PMC4375645/ /pubmed/25844314 http://dx.doi.org/10.1016/j.nicl.2015.02.016 Text en © 2015 The Authors. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Regular Article Haris, Mohammad Yadav, Santosh K. Rizwan, Arshi Singh, Anup Cai, Kejia Kaura, Deepak Wang, Ena Davatzikos, Christos Trojanowski, John Q. Melhem, Elias R. Marincola, Francesco M. Borthakur, Arijitt T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease |
title | T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease |
title_full | T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease |
title_fullStr | T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease |
title_full_unstemmed | T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease |
title_short | T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease |
title_sort | t1rho mri and csf biomarkers in diagnosis of alzheimer's disease |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375645/ https://www.ncbi.nlm.nih.gov/pubmed/25844314 http://dx.doi.org/10.1016/j.nicl.2015.02.016 |
work_keys_str_mv | AT harismohammad t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease AT yadavsantoshk t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease AT rizwanarshi t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease AT singhanup t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease AT caikejia t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease AT kauradeepak t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease AT wangena t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease AT davatzikoschristos t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease AT trojanowskijohnq t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease AT melhemeliasr t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease AT marincolafrancescom t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease AT borthakurarijitt t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease |